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Abstract
Staphylococcus aureus is the most common pathogen cultured from diabetic foot infection (DFI). The consequence of its spread to soft tissue
and bony structures is a major causal factor for lower-limb amputation. The objective of the study was to explore ecological data and
epidemiological characteristics of S. aureus strains isolated from DFI in an Algerian hospital setting. Patients were included if they were
admitted for DFI in the Department of Diabetology at the Annaba University Hospital from April 2011 to March 2012. Ulcers were
classiﬁed according to the Infectious Diseases Society of America/International Working Group on the Diabetic Foot classiﬁcation system.
All S. aureus isolates were analysed. Using oligonucleotide arrays, S. aureus resistance and virulence genes were determined and each isolate
was afﬁliated to a clonal complex. Among the 128 patients, 277 strains were isolated from 183 samples (1.51 isolate per sample). Aerobic
Gram-negative bacilli were the most common isolated organisms (54.9% of all isolates). The study of ecological data highlighted the
extremely high rate of multidrug-resistant organisms (MDROs) (58.5% of all isolates). The situation was especially striking for S. aureus
[(85.9% were methicillin-resistant S. aureus (MRSA)], Klebsiella pneumonia (83.8%) and Escherichia coli (60%). Among the S. aureus isolates,
82.2% of MRSA belonged to ST239, one of the most worldwide disseminated clones. Ten strains (13.7%) belonged to the European clone
PVL+ ST80. ermA, aacA-aphD, aphA, tetM, fosB, sek, seq, lukDE, fnbB, cap8 and agr group 1 genes were signiﬁcantly associated with MRSA
strains (p <0.01). The study shows for the ﬁrst time the alarming prevalence of MDROs in DFI in Algeria.
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Introduction
Diabetes mellitus is a serious public health problem that is
rapidly expanding worldwide [1]. According to the National
Institute of Public Health TAHINA survey, the prevalence of
diabetes was around 8% in Algeria in a population ranging from
35 to 70 years [2]. Foot ulcers are a common complication in
diabetic patients, with prevalence as high as 15–25% [3]. These
ulcers frequently become infected, and spread of infection to
soft tissue and bony structures is a major causal factor for
lower-limb amputation [4], making early diagnosis and ade-
quate treatment essential. As microorganisms are normally
present on skin wounds, diagnosis of infection must be based
not on microbiological ﬁndings but on symptoms and clinical
signs, as emphasized by the Infectious Diseases Society of
America (IDSA), the International Working Group on the
Diabetic Foot (IWGF) and the French Society for Infectious
Pathology [4]. However, due to the confounding effect of
neuropathy and ischaemia on local and systemic inﬂammatory
responses, diagnosing diabetic foot infection (DFI) at an early
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stage is often difﬁcult, resulting in misuse of antibiotics [4].
Conversely, inappropriate antibiotic usage contributes to the
increasing prevalence of multidrug-resistant organisms
(MDROs), notably methicillin-resistant S. aureus (MRSA) [5–
10]. To date very few epidemiological data are available about
S. aureus strains isolated in diabetic foot ulcers (DFUs) and we
are not aware of any such study that was performed in Algeria.
In this country, the European community-acquired MRSA
clone ST80-IV harbouring Panton–Valentine leukocidin (PVL) is
responsible for more than one-third of both community and
hospital infections [11,12]. Considering the high prevalence of
diabetes mellitus in Algeria and the few data available about
pathogens involved in DFI in this country, we decided to
identify bacteria responsible for this condition; more speciﬁ-
cally we aimed to determine the prevalence and the genotyping
proﬁles of S. aureus from an Algerian hospital setting and to
compare our data with those published in other countries.
Finally, the identiﬁcation of the role of MDROs in DFI might
help clinicians to choose antibiotic agents in a more rational
way.
Materials and Methods
Prospective study
Between 1 April 2011 and 30 March 2012, we prospectively
enrolled all diabetic patients admitted to the Department of
Endocrinology and Diabetology at Annaba University hospital
(Algeria) for DFI. Patients were included if they had not
received any antibiotic agents in the previous week. This study
was carried out in accordance with the Declaration of Helsinki
as revised in 2000. The presence and severity of DFI (grade 2–
4) were assessed using the IDSA-IWGDF classiﬁcation system
[4].
After wound debridement, samples for bacterial culture
were obtained by scraping the wound base and collecting
debris by swabbing the wound base, needle aspiration or tissue
biopsy and immediately sent to the bacteriology department.
Patients with PVL+ strains were monitored at 6 months to
assess the wound outcome (healing/worsening).
Microbiological study
S. aureus was identiﬁed by conventional methods (Gram-positive
cocci, catalase positive, mannitol fermenting, ability to coagulate
rabbit plasma) (BioMerieux, Marcy-l’Etoile, France) and Pastorex
Staph Plus agglutination (BioMerieux). Antimicrobial sensitivity
was determined by the disk diffusion method according to
recommendations of the Antibiotic Committee of the French
Society for Microbiology (http://www.sfm-microbiologie.org/
pages/?page=746&id_page=182). Susceptibility to methicillin was
screened by agar diffusion using cefoxitin disks (BioRad, Marnes-
La-Coquette, France). The S. aureus strains isolated during the
inclusion period were preserved in deep agar gel. To be classiﬁed
as a multidrug-resistant organism (MDRO), S. aureus should be
methicillin resistant and Gram-negative bacilli resistant to the
third generation cephalosporins (3GC). Those isolates included
3GC-resistant Enterobacteriaceae, Pseudomonas aeruginosa and
Acinetobacter baumannii resistant to ceftazidime.
Oligonucleotide DNA arrays and genotyping
Each S. aureus isolate collected during the study was analysed
at the INSERM laboratory in N^ımes, France. The Alere
StaphyType DNA microarray was used according to proto-
cols and procedures previously detailed [13,14]. The test was
performed in 5 h. The DNA microarray covers 333 target
sequences, including species markers, SCCmec, capsule and
agr group typing markers, resistance genes, exotoxins and
MSCRAMM (microbial surface components recognizing adhe-
sive matrix molecules) genes. Primer and probe sequences
have been previously published [13]. The S. aureus strains
were grown on Columbia blood agar and incubated overnight
at 37°C. Culture material was enzymatically lysed prior to
DNA preparation using commercially available spin columns
(Qiagen, Hilden, Germany). Puriﬁed DNA samples were used
as templates in a linear primer elongation with one primer
per target. All targets were ampliﬁed simultaneously and,
during this step, biotin-16-dUTP was incorporated into the
resulting amplicons. Then amplicons were hybridized to the
microarray, washed and blocked before addition of horse-
radish-peroxidase-streptavidin conjugate. After further incu-
bation and washing steps, hybridizations were visualized as
spots using a precipitating dye. A digital picture of the
microarray was taken and analysed using a dedicated reader
and software (ALERE Technologies, GmbH, Jena, Germany).
The afﬁliation of isolates to clonal complexes (CCs) or
sequence types (STs) as deﬁned by MLST [14] was deter-
mined by an automated comparison of hybridization proﬁles
with a collection of reference strains previously characterized
[13,14]. A CC may be deﬁned as a cluster of strains (clones)
that are close enough together to be claimed to share to a
common origin.
Statistical analysis
The presence of methicillin resistance in S. aureus strains was
analysed according to demographic and clinical characteristics
of study patients and the repartition of the different virulence
genes using Fisher’s exact test. Statistical analysis was
performed using the S-Plus 2000 software package (Insightful
Corporation, Seattle, WA, USA) and results were considered
signiﬁcant for p <0.05.
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Results
Clinical data and microbiological considerations
From April 2011 to March 2012, 128 patients were hospital-
ized for DFI and included in the study. Two hundred and
seventy-seven strains were isolated (Table 1) from 183
samples, corresponding to a mean number of 1.51 isolates
per sample. A polymicrobial infection was present in 92
samples (six with four bacteria, 17 with three bacteria, 69 with
two germs). In 64 samples, infection was monomicrobial and
27 cultures were negative. Aerobic Gram-negative bacilli were
the most commonly isolated microorganisms (54.9% of all
isolates). Among them, Enterobacteriaceae were the most
frequent (43.7% of all isolates), especially Proteus sp. (34.7% of
enterobacteria). Non-fermentative Gram-negative bacilli were
rather uncommon (11.2% of all isolates). Aerobic Gram-
positive cocci accounted for 45.1% of all organisms, with
S. aureus as the most commonly isolated pathogen (n = 85, i.e.
30.7% of the aerobic bacteria and 68% of the Gram-positive
cocci). Surprisingly, Streptococcus sp. was very rarely detected
(0.7% of all isolates). No anaerobes were isolated. A high
number of isolates were MDRO (58.5%). MRSA was the most
common resistant bacteria (85.9% of S. aureus, 45.1% of all
resistant isolates). Among Gram-negative bacilli, 57% of
enterobacteria were multidrug resistant, with a dramatically
high percentage of Klebsiella pneumonia (83.8%) and Escherichia
coli (60%). Moreover all Acinetobacter baumannii and more than
half of P. aeruginosa were MDRO.
As previously mentioned, S. aureus was isolated in 85
patients from the bacterial culture of their infected wound.
The demographic and clinical characteristics of these patients
are shown in Table 2. Twenty-one DFIs (24.7%) were
classiﬁed as grade 2, 55 as grade 3 (64.7%) and nine as grade
4 (10.6%). In 40 patients (47.1%) the current wound was the
ﬁrst episode of ulceration. Sixteen wounds (18.8%) were
associated with osteomyelitis. There was no signiﬁcant differ-
ence in the baseline characteristics of patients regarding
whether their wounds were infected by methicillin-sensitive
S. aureus (MSSA) or MRSA, except that previous antibiotic
treatment was signiﬁcantly more frequent in patients with
MRSA strains (p 0.007) (Table 2).
Antimicrobial susceptibility of S. aureus
The in vitro activities of antimicrobial agents against the 85
S. aureus isolates demonstrated a high level of resistance to
all classical antistaphylococcal treatments.
All MSSA isolates were susceptible to pristinamycin,
fosfomycin and glycopeptides. Gentamicin was the most active
aminoglycoside (41.6%). Regarding MRSA, only glycopeptides
were active against all the isolates. Compared with MSSA, a
signiﬁcantly higher percentage of MRSA was resistant to some
antimicrobial agents, including aminoglycosides, quinolones,
cotrimoxazole and tetracycline (p <0.01).
Clonal complexes (CCs) distribution of S. aureus
Using the DNA arrays technology, all the S. aureus strains we
isolated were analysed. The majority of the 73 MRSA belonged
to Brazilian clone ST239 (n = 60, 82.2%). Ten strains (13.7%)
were assigned to the European clone ST80 and the last three
(4.1%) to a CC unknown in the database.
Regarding MSSA, they belonged to a great diversity of CCs:
CC1 (n = 3), CC15 (n = 3), CC121 (n = 2), CC9 (n = 1),
CC54 (n = 1) and ST152 (n = 1). One isolate was contained in
a CC unknown in the database. Concerning the strains isolated
from bone, all were MRSA; 14 belonged to ST239 and two to
clone ST80.
Resistance and virulence proﬁles
The prevalence of resistance and virulence determinants are
summarized in Table 3.
Analysis of the resistance genes completely agreed with
conventional susceptibility data. All MRSA isolates were
detected by the cefoxitin test and were positive for mecA
and SCCmec cassette by DNA arrays. The most prevalent
macrolide resistance gene in MRSA strains was ermA, which
was detected in 39.7% (n = 29) of the isolates, whereas ermC
was found as a single erm gene in 16.6% (n = 2) of MSSA
isolates. The aminoglycoside resistance genes were found only
in MRSA strains; aphA and aacA-aphD were the most prevalent
genes (95.9% and 90.4% of the isolates, respectively). The
tetracycline resistance genes (tet efﬂux genes) were detected
TABLE 1. Bacteriological aetiology of diabetic foot infec-
tions
Microorganism(s) N (%)
Multidrug-resistant
bacteriaa (%)
Gram-positive aerobic cocci 125 (45.1)
Staphylococcus aureus 85 (30.7) 73 (85.9)
Enterococcus faecalis 7 (2.5) –
Coagulase-negative Staphylococcus 31 (11.2) –
Streptococcus spp. 2 (0.7) –
Gram-negative aerobic bacilli 152 (54.9)
Proteus mirabilis 35 (12.6) 12 (34.3)
Klebsiella pneumoniae 31 (11.2) 26 (83.8)
Escherichia coli 20 (7.2) 12 (60)
Morganella morganii 15 (5.4) 8 (53.3)
Enterobacter cloacae 9 (3.2) 5 (55.5)
Proteus vulgaris 7 (2.5) 4 (57.1)
Providencia stuartii 2 (0.7) 1 (50)
Klebsiella oxytoca 1 (0.4) 1 (100)
Citrobacter spp. 1 (0.4) –
Pseudomonas aeruginosa 23 (8.3) 12 (52.1)
Acinetobacter baumannii 8 (2.9) 8 (100)
aMultidrug-resistant bacteria included methicillin-resistant S. aureus, Enterobacte-
riaceae resistant to third-generation cephalosporin, P. aeruginosa or Acinetobacter
baumannii resistant to ceftazidime.
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in 98.6% (n = 84) of the isolates. Compared with MSSA, MRSA
strains exhibited a signiﬁcantly higher prevalence rate for ermA,
aacA-aphD, aphA, sat, tetM and fosB genes (p <0.01). No van
genes were detected, in agreement with the in vitro suscep-
tibility data.
Strains were characterized by some distinctive features
regarding the distribution of virulence factors: high prevalence
of enterotoxins (sek (n = 65, 76.5%), seq (n = 64, 75.3%) and
sea (n = 38, 44.7%)), haemolysins (hlg, hlgv, hlgA, hld), genes
encoding intracellular adhesion proteins (icaA, icaC, icaD) and
capsular polysaccharide type 8 (n = 81, 95.3%), together with
four genes encoding MSCRAMM (ebpS, clfA, clfB, fnbA). A
majority of the isolates were found in agr group 1 (n = 64,
75.3%). seb, egc cluster, seh, hla, cap5 and agr group 2 were
signiﬁcantly more prevalent in MSSA strains and sek, seq, lukDE,
fnbB, cap8, and agr group 1 in MRSA strains (p <0.01). Genes
encoding exfoliatin A and B toxins were not found. On the
other hand, etD was detected in ten (11.8%) strains. DNA
array analysis revealed that 12.9% (n = 11) of isolates were
edinB positive. In ten strains, edin-B and etD genes were found
to be associated. Genes encoding PVL were detected in 11
MRSA isolates (15%) and in one MSSA isolate (8.3%). All these
strains belonged to the CC80-MRSA (European community
MRSA Clone). A 6-month follow-up of the patients harbouring
these strains demonstrated that all of them had a poor
outcome (amputations).
Discussion
This study highlighted the extremely high rate of MDRO
(58.5%) in DFI from Algerian patients. The prevalence of
MDRO was especially striking for S. aureus (85.9% of MRSA
among staphylococci), Klebsiella pneumonia (83.8%) and Escher-
ichia coli (60%). This burden of resistance might be directly
associated with DFI because a national survey highlighted that
the MRSA rate is 35% in Algeria, increasing to 40.7% for
hospitalized patients (www.sante.dz/aarn/documents/pdf/rap
port11.pdf). The same trend was found for K. pneumoniae
(52.5% were resistant to cefotaxime) and E. coli (13.4%).
Another surprising feature was the predominance of Gram-
positive cocci as S. aureus is considered to be the most
TABLE 2. Demographic and clinical characteristics of study patients
Characteristics
Valuea
p
Patients with MSSA
n = 12
Patients with MRSA
n = 73
Total
n = 85 MSSA vs. MRSA
Age (range), years 63 (47–82) 64.5 (23–83) 64 (23–83) NS
Male/female, n (%) 7 (58.3) / 5 (41.7) 46 (63)/27 (37) 53 (62.3)/32 (37.7) NS
Type 1/Type 2 diabetes mellitus 2/10 16/57 18/67
Cardiovascular disease
Absence 4 (33.3) 18 (24.6) 22 (25.9) NS
Coronary heart disease 0 (0) 8 (11) 8 (9.4) NS
Peripheral arterial disease 7 (58.3) 46 (63) 53 (62.3) NS
Arterial hypertension 9 (75) 43 (58.9) 52 (61.1) NS
Stroke 1 (8.3) 2 (2.7) 3 (3.5) NS
Nephropathy
Absence 7 (58.3) 32 (43.8) 39 (45.9) NS
Microalbuminuria 1 (8.3) 13 (17.8) 14 (16.4) NS
Proteinuria 2 (16.7) 17 (23.3) 19 (22.3) NS
Renal failure 3 (25) 15 (20.5) 18 (21.2) NS
Neuropathy
Peripheral 10 (83.3) 56 (76.7) 66 (77.6) NS
Autonomic 0 (0) 5 (6.8) 5 (5.9) NS
Diabetic retinopathy
Absence 5 (41.7) 21 (28.7) 26 (30.6) NS
Non-proliferative diabetic retinopathy 5 (41.7) 41 (56.1) 46 (54.1) NS
Proliferative diabetic retinopathy 2 (16.7) 11 (15.1) 13 (15.3) NS
Lifestyle factors
Obesity 5 (41.7) 15 (20.5) 20 (23.5) NS
Smoking 2 (16.7) 13 (17.8) 15 (17.6) NS
Alcoholism 1 (8.3) 2 (2.7) 3 (3.5) NS
Sedentary 6 (50) 23 (31.5) 29 (34.1) NS
First wound/ recurrence 7 (58.3)/5 (41.7) 33 (45.2)/40 (54.8) 40 (47.1)/45 (52.9) NS
Prior antibiotic therapy 8 (66.7) 70 (95.9) 78 (91.7) 0.007
b-Lactams 6 (50) 53 (72.6) 59 (69.4) NS
Aminoglycosides 1 (8.3) 7 (9.6) 8 (9.4) NS
Quinolones 2 (16.7) 9 (12.3) 11 (12.9) NS
Macrolides 0 (0) 12 (16.4) 12 (14.1) NS
IDSA grade
2 4 (33.3) 17 (23.3) 21 (24.7) NS
3 8 (66.7) 47 (64.4) 55 (64.7) NS
4 0 (0) 9 (12.3) 9 (10.6) NS
Samples
Scraping-swabbing 12 (100) 63 (86.3) 75 (88.2) NS
Needle aspiration 0 (0) 6 (8.2) 6 (7.1) NS
Tissue/bone biopsy 0 (0) 4 (5.5) 4 (4.7) NS
NS, not signiﬁcant.
*Values are numbers and percentages in brackets.
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frequently isolated and virulent pathogen in DFI from western
countries [15–17]. However, some recent studies have shown
that Gram-negative organisms are the most frequent isolates in
DFI from patients living in warm climates, especially in India [18
–20]. As noted by Lipsky et al. [4], there is no clear explanation
for this predominance.
The increasing prevalence of antibiotic-resistant bacteria in
DFUs, particularly MRSA, both as colonizers or pathogens [6–
8], is problematic. MRSA has emerged as a serious and
commonly occurring problem in diabetic patients with foot
ulcers [5,7]. MRSA requires targeted antibiotic treatment and
has been associated with a poor outcome in many reports
[9,10,21]. In this study, we focused for the ﬁrst time on
S. aureus isolated from DFIs in Annaba University Hospital
(Algeria). Even though Gram-negative bacilli as a group were
the most prevalent bacteria isolated in our study, S. aureus was
the most common isolate (Table 1), accounting for 30.7% of all
microorganisms, and 85.9% of S. aureus were methicillin
resistant, in agreement with other studies [5,15,17,22,23].
However, the rate of methicillin resistance is particularly high,
ranging from 15 to 30% around the world [24]. While the
MRSA prevalence rate is clearly high in Annaba Hospital (62.5%
of all S. aureus isolated in 2011 were MRSA), it is signiﬁcantly
lower than in strains isolated from DFIs (p <0.001). This high
prevalence rate is associated with previous antibiotic treat-
ment in our study and is likely to be attributable to the high
proportion of patients with recurrent ulcers (55%): all were
previously infected and had been already treated with
antibiotics during a preceding hospitalization, a well-established
risk factor for selecting antibiotic-resistant organisms, especially
in a diabetic foot clinic [3,4,8]. b-Lactams were the most
prescribed antibiotic treatment in this population. Potential
sourcesof acquisitionofMRSAmay includepriorhospitalizations
andtransmissionbyhealthcareprovidersathomeduringdressing
changes. Even if MRSA is considered to be a colonizer, we could
observe in this population that all the osteomyelitis was due to
MRSA strains, suggesting that if a rapid debridement is not
performed all the strains are a source of serious complications in
chronic wounds.
DNA microarray is a technique from molecular biology that
is able to detect genes related to virulence and antibiotic
resistance [13,14]. Using this method, we were able to
compare the strains, determine their clonality and evaluate the
virulence and resistance proﬁles of S. aureus [13,14]. In our
study, 82.2% of the MRSA isolates we tested belonged to
ST239; this clone is considered to be one of the most
worldwide disseminated clones [25], being extensively
described as a major clone in many countries in Asia, Europe,
South America [26] and Africa [27]. It has not been described
in Algeria to date. Interestingly, in this study we highlighted the
importance of strains harbouring Panton–Valentine leukocidin-
encoding genes (n = 12, 14.1%). These genes coding for a
cytotoxin are claimed to be a major threat in severe tissue
necrosis [28] in some but not all previously published studies.
This high prevalence is unknown in this pathology, where these
strains are rarely isolated from chronic wounds [22,23] and
their pathogenicity is low in this setting [29]. In this study, all
PVL+ MRSA stains belonged to CC80; this clone has been
considered to be the main clone associated with PVL in Europe
[30], and also in Algeria [11] and Tunisia [31]. The high
prevalence of this clone in Algeria could explain its detection in
DFI. However, more surprisingly, all the patients harbouring
PVL+ strains had a worse outcome, a result not found in a
previous study [29]. Differences in wound care and treatment
TABLE 3. Main virulence proﬁles and resistance determi-
nants of S. aureus isolated from diabetic foot ulcers
MSSA
n = 12
MRSA
n = 73
TOTAL
n = 85
p
MSSA vs. MRSA
Virulence genotyping
Enterotoxins
sea 4 (33.3) 34 (46.5) 38 (44.7) NS
seb 3 (25) 0 (0) 3 (3.5) 0.002
egc cluster 5 (41.6) 2 (2.7) 7 (8.2) <0.001
seh 3 (25) 0 (0) 3 (3.5) 0.002
sek 3 (25) 62 (85) 65 (76.5) <0.001
seq 3 (25) 61 (83.5) 64 (75.3) <0.001
Other toxins
tst 0 (0) 0 (0) 0 (0) NS
etA 0 (0) 0 (0) 0 (0) NS
etB 0 (0) 0 (0) 0 (0) NS
etD 0 (0) 10 (13.7) 10 (11.8) NS
edinA 0 (0) 0 (0) 0 (0) NS
edinB 1 (8.3) 10 (13.7) 11 (12.9) NS
lukS-PV/lukF-PV 1 (8.3) 11 (15) 12 (14.1) NS
lukDE 9 (75) 73 (100) 82 (96.5) 0.02
Haemolysins
hla 12 (100) 12 (16.4) 24 (28.2) <0.001
hld 12 (100) 73 (100) 85 (100) NS
hlgA 12 (100) 73 (100) 85 (100) NS
hlg 12 (100) 73 (100) 85 (100) NS
hlgv 12 (100) 73 (100) 85 (100) NS
MSCRAMM
bbp 12 (100) 72 (98.6) 84 (98.8) NS
cna 7 (58.3) 62 (84.9) 69 (81.2) NS
ebpS 12 (100) 73 (100) 85 (100) NS
clfA 12 (100) 73 (100) 85 (100) NS
clfB 12 (100) 73 (100) 85 (100) NS
ﬁb 10 (83.3) 73 (100) 83 (97.6) NS
fnbA 12 (100) 73 (100) 85 (100) NS
fnbB 0 (0) 60 (82.2) 60 (70.6) <0.001
Capusles
cap5 3 (25) 1 (1.3) 4 (4.7) 0.008
cap8 9 (75) 72 (98.6) 81 (95.3) 0.008
Other virulent factors
chp 6 (50) 33 (45.2) 39 (45.9) NS
scn 12 (100) 72 (98.6) 84 (98.8) NS
Accessory gene regulator
agr1 2 (1.6) 62 (84.9) 64 (75.3) <0.001
agr2 5 (41.6) 2 (2.7) 7 (8.2) <0.001
agr3 3 (25) 10 (13.7) 13 (15.3) NS
agr4 3 (25) 16 (21.9) 19 (22.4) NS
Resistance genes
mecA 0 (0) 73 (100) 73 (85.9) <0.001
ermA 0 (0) 29 (39.7) 29 (34.1) 0.004
ermC 2 (16.7) 1 (1.3) 3 (3.5) 0.05
aacA-aphD 0 (0) 66 (90.4) 66 (77.6) <0.001
aphA 0 (0) 70 (95.9) 70 (82.4) <0.001
sat 0 (0) 70 (95.9) 70 (82.4) <0.001
tetM 0 (0) 63 (86.3) 63 (74.1) <0.001
tet efﬂux 12 (100) 72 (98.6) 84 (98.8) NS
fosB 8 (66.6) 64 (100) 72 (84.7) 0.03
NS, not signiﬁcant.
*Values are numbers and percentages in brackets.
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compliance or indications for lower-limb amputations could
explain these differences.
One of the limitations of the study is the high number of swab
samples (93%) but these samples were obtained after scraping
the base of the ulcers, as recommended by the IWGDF [4].
Moreover, the number of isolates per sample was low,
suggesting that the samplingmethodwas rather in adequate [32].
In conclusion, this study highlighted for the ﬁrst time the
bacterial ecology of DFI in an Algerian hospital, showing a high
prevalence of MDRO, notably MRSA strains and a high
proportion of Gram-negative bacilli. These features appear
close to those previously described in India [18–20]. This trend
is alarming and could indicate a misuse of antibiotic agents and/
or high prevalence of cross-transmission of microorganisms.
Improving knowledge of the local ecology of DFI in Annaba
looks to be important for a more rational empirical prescrip-
tion of antibiotic agents in Algeria if such results are conﬁrmed
by further studies in other Algerian areas.
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